Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
about
Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states.Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors.The in vitro actions of loxapine on dopaminergic and serotonergic receptors. Time to consider atypical classification of this antipsychotic drug?
P2860
Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@en
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@nl
type
label
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@en
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@nl
prefLabel
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@en
Preclinical evaluation of [18F ...... 6 radioligand for PET imaging.
@nl
P2093
P2860
P1476
Preclinical evaluation of [18F ...... T6 radioligand for PET imaging
@en
P2093
Guillaume Becker
Julie Colomb
Léon Tremblay
Véronique Sgambato-Faure
P2860
P2888
P304
P356
10.1007/S00259-014-2936-Y
P577
2014-10-21T00:00:00Z